Cargando…

Functional Profiling of Live Melanoma Samples Using a Novel Automated Platform

AIMS: This proof-of-concept study was designed to determine if functional, pharmacodynamic profiles relevant to targeted therapy could be derived from live human melanoma samples using a novel automated platform. METHODS: A series of 13 melanoma cell lines was briefly exposed to a BRAF inhibitor (PL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schayowitz, Adam, Bertenshaw, Greg, Jeffries, Emiko, Schatz, Timothy, Cotton, James, Villanueva, Jessie, Herlyn, Meenhard, Krepler, Clemens, Vultur, Adina, Xu, Wei, Yu, Gordon H., Schuchter, Lynn, Clark, Douglas P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532357/ https://www.ncbi.nlm.nih.gov/pubmed/23285177 http://dx.doi.org/10.1371/journal.pone.0052760

Ejemplares similares

The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling
por: Desai, Brijal M., et al.
Publicado: (2013)

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma
por: Krepler, Clemens, et al.
Publicado: (2016)

PIM kinases as therapeutic targets against advanced melanoma
por: Shannan, Batool, et al.
Publicado: (2016)

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma
por: Liu, Shujing, et al.
Publicado: (2017)

Narrowing the knowledge gaps for melanoma
por: Slipicevic, Ana, et al.
Publicado: (2012)

Gene expression profiling of melanoma cells – searching the haystack
por: Brafford, Patricia, et al.
Publicado: (2005)

Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma
por: Bogenrieder, Thomas, et al.
Publicado: (2002)

Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma
por: Echevarría‐Vargas, Ileabett M, et al.
Publicado: (2018)

A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells
por: Stejerean-Todoran, Ioana, et al.
Publicado: (2022)

Pre-clinical modeling of cutaneous melanoma
por: Rebecca, Vito W., et al.
Publicado: (2020)

From cancer stem cells to tumor maintenance in melanoma
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2011)

Preclinical platforms to study therapeutic efficacy of human γδ T cells
por: Ou, Lingling, et al.
Publicado: (2022)

Autophagy Paradox: Strategizing Treatment Modality in Melanoma
por: Pangilinan, Christian, et al.
Publicado: (2023)

Matricellular Proteins Produced by Melanocytes and Melanomas: In Search for Functions
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2008)

NUMB as a Therapeutic Target for Melanoma
por: Hristova, Denitsa M., et al.
Publicado: (2022)

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
por: Li, Ling, et al.
Publicado: (2011)

Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches
por: Maurer, Margarita, et al.
Publicado: (2012)

GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation
por: John, Jobin K., et al.
Publicado: (2012)

Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance
por: Liu, Jianglan, et al.
Publicado: (2021)

Patient-derived melanoma organoid models facilitate the assessment of immunotherapies
por: Ou, Lingling, et al.
Publicado: (2023)

Expression of Integrin Alpha10 Is Induced in Malignant Melanoma
por: Wenke, Ann-Kathrin, et al.
Publicado: (2007)

Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States
por: Zhang, Shujing, et al.
Publicado: (2023)

Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation
por: Kim, Hyungsoo, et al.
Publicado: (2015)

PAK Signaling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas
por: Lu, Hezhe, et al.
Publicado: (2017)

TRIM15 and CYLD regulate ERK activation via lysine 63-linked polyubiquitination
por: Zhu, Guixin, et al.
Publicado: (2021)

Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas
por: Rebecca, Vito W., et al.
Publicado: (2023)

Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population
por: Fukunaga-Kalabis, Mizuho, et al.
Publicado: (2010)

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014)

Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma
por: Wang, Beike, et al.
Publicado: (2021)

Challenges in the humanized mouse model for cancer: A commentary
por: Ramirez-Salazar, Eric, et al.
Publicado: (2021)

MCU controls melanoma progression through a redox‐controlled phenotype switch
por: Stejerean‐Todoran, Ioana, et al.
Publicado: (2022)

Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity
por: Liu, Wei, et al.
Publicado: (2020)

Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma
por: Das, Ishani, et al.
Publicado: (2020)

The macrophage: Switches from a passenger to a driver during anticancer therapy
por: Wang, Tao, et al.
Publicado: (2015)

An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma
por: Lorenzi, Maria, et al.
Publicado: (2019)

Antimelanoma CTL recognizes peptides derived from an ORF transcribed from the antisense strand of the 3′ untranslated region of TRIT1
por: Swoboda, Rolf K, et al.
Publicado: (2015)

Pembrolizumab Utilization and Clinical Outcomes Among Patients With Advanced Melanoma in the US Community Oncology Setting: An Updated Analysis
por: Cowey, Charles Lance, et al.
Publicado: (2021)

IL8 and Cathepsin B as Melanoma Serum Biomarkers
por: Zhang, Hongtao, et al.
Publicado: (2011)

Persister state-directed transitioning and vulnerability in melanoma
por: Chauvistré, Heike, et al.
Publicado: (2022)

Naïve adult stem cells from patients with Hutchinson-Gilford progeria syndrome express low levels of progerin in vivo
por: Wenzel, Vera, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9hu7fsodtn6dia3if94lsosoig